
“For the second time in recent months, a scientific paper published in a peer-reviewed journal has thoroughly rebutted the present Schedule I status of cannabis under US federal law. According to a just published review in the German scientific journal Deutsches Ärzteblatt International, scientific findings from over 100 controlled clinical trials involving either cannabis or its constituents provide ‘clear evidence that cannabinoids are useful for the treatment of various medical conditions.'”
Related posts:
Reclaiming our Police Forces
Cyprus-Style Wealth Confiscation Starting To Happen All Over The Globe
Doubt cast on 1953 U.S. execution of Cold War spy's wife
BitScan's exclusive Q&A with Roger Ver
Court ruling conceals public safety info due to potential ‘terrorists’
12,000 Peaceful People Arrested in Italy for Not Paying Taxes; Police Discover Thriving Black Market
Luzi Stamm: champion of a new Swiss gold initiative
Linux bug leaves USA Today, other top sites vulnerable to serious hijacking attacks
US Department of Treasury Targets Bitcoin Poker Sites
Bitcoin’s Sixth Year Likely Driven By Institutional Participation
Trump’s Ban on Muslims Is Unconstitutional and Obscures Real Solution
U.S. traveler finds feds kept a 76-page file on him, including credit cards
Developers Scramble to Build NSA-Proof Email
Swiss to Vote on Initiative to Return Gold Stored in the US to Switzerland
Privacy services companies stand up against Big Brother